Epitope topography of agonist antibodies to the checkpoint inhibitory receptor BTLA.

[1]  D. Olive,et al.  BTLA inhibition has a dominant role in the cis-complex of BTLA and HVEM , 2022, Frontiers in Immunology.

[2]  S. Peterson,et al.  Btla signaling in conventional and regulatory lymphocytes coordinately tempers humoral immunity in the intestinal mucosa , 2021, Cell reports.

[3]  J. Cyster,et al.  T follicular helper cells in germinal center B cell selection and lymphomagenesis , 2020, Immunological reviews.

[4]  Kongming Wu,et al.  Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4 , 2019, Molecular Cancer.

[5]  D. Davar,et al.  Immunological Targets for Immunotherapy: Inhibitory T Cell Receptors. , 2019, Methods in molecular biology.

[6]  Simon C. Potter,et al.  The EMBL-EBI search and sequence analysis tools APIs in 2019 , 2019, Nucleic Acids Res..

[7]  J. Leitner,et al.  Not All Immune Checkpoints Are Created Equal , 2018, Front. Immunol..

[8]  Brian C. Ware,et al.  A herpesvirus entry mediator mutein with selective agonist action for the inhibitory receptor B and T lymphocyte attenuator , 2017, The Journal of Biological Chemistry.

[9]  D. Vignali,et al.  Co-stimulatory and Co-inhibitory Pathways in Autoimmunity. , 2016, Immunity.

[10]  C. Ware,et al.  The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory Responses. , 2016, Immunity.

[11]  G. Freeman,et al.  Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family. , 2016, Immunity.

[12]  G. Freeman,et al.  Coinhibitory Pathways in Immunotherapy for Cancer. , 2016, Annual review of immunology.

[13]  K. Schmetterer,et al.  Assessment of costimulation and coinhibition in a triple parameter T cell reporter line: Simultaneous measurement of NF-κB, NFAT and AP-1. , 2016, Journal of immunological methods.

[14]  Matthew G. Macauley,et al.  The inhibitory receptor BTLA controls γδ T cell homeostasis and inflammatory responses. , 2013, Immunity.

[15]  C. Ware,et al.  The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulation , 2011, Immunological reviews.

[16]  R. Goody,et al.  The original Michaelis constant: translation of the 1913 Michaelis-Menten paper. , 2011, Biochemistry.

[17]  M. Kronenberg,et al.  Regulation of inflammation, autoimmunity, and infection immunity by HVEM‐BTLA signaling , 2011, Journal of leukocyte biology.

[18]  Matthew G. Macauley,et al.  T Cell Intrinsic Heterodimeric Complexes between HVEM and BTLA Determine Receptivity to the Surrounding Microenvironment1 , 2009, The Journal of Immunology.

[19]  G. Freeman,et al.  The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T‐cell activation , 2009, Immunological reviews.

[20]  Matthew G. Macauley,et al.  Unconventional ligand activation of herpesvirus entry mediator signals cell survival , 2009, Proceedings of the National Academy of Sciences.

[21]  D. Arnott,et al.  B and T Lymphocyte Attenuator Regulates B Cell Receptor Signaling by Targeting Syk and BLNK , 2009, The Journal of Immunology.

[22]  G. Freeman,et al.  CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator , 2008, Nature Immunology.

[23]  K. Murphy,et al.  Combined Coinhibitory and Costimulatory Modulation with Anti‐BTLA and CTLA4Ig Facilitates Tolerance in Murine Islet Allografts , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[24]  S. Hymowitz,et al.  Attenuating Lymphocyte Activity , 2005, Journal of Biological Chemistry.

[25]  K. Murphy,et al.  Differential Effects of B and T Lymphocyte Attenuator and Programmed Death-1 on Acceptance of Partially versus Fully MHC-Mismatched Cardiac Allografts1 , 2005, The Journal of Immunology.

[26]  C. Benedict,et al.  Evolutionarily divergent herpesviruses modulate T cell activation by targeting the herpesvirus entry mediator cosignaling pathway. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[27]  P. Ramakrishnan,et al.  TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[28]  C. Ware,et al.  Constitutive Expression of LIGHT on T Cells Leads to Lymphocyte Activation, Inflammation, and Tissue Destruction1 2 , 2001, The Journal of Immunology.

[29]  T. Ayres,et al.  Herpesvirus Entry Mediator, a Member of the Tumor Necrosis Factor Receptor (TNFR) Family, Interacts with Members of the TNFR-associated Factor Family and Activates the Transcription Factors NF-κB and AP-1* , 1997, The Journal of Biological Chemistry.

[30]  P. Spear,et al.  Herpes Simplex Virus-1 Entry into Cells Mediated by a Novel Member of the TNF/NGF Receptor Family , 1996, Cell.

[31]  M. Azuma,et al.  The CD28-B7 Family of Co-signaling Molecules. , 2019, Advances in experimental medicine and biology.

[32]  Weifeng Liu,et al.  Structures of Immune Checkpoints: An Overview on the CD28-B7 Family. , 2019, Advances in experimental medicine and biology.

[33]  C. Ware,et al.  B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator , 2005, Nature Immunology.

[34]  G. Freeman,et al.  The B7 family revisited. , 2005, Annual review of immunology.

[35]  T. Schwartz,et al.  Steric hindrance mutagenesis versus alanine scan in mapping of ligand binding sites in the tachykinin NK1 receptor. , 1998, Molecular pharmacology.

[36]  C. Ware,et al.  LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. , 1998, Immunity.

[37]  A. Cornish-Bowden.  A simple graphical method for determining the inhibition constants of mixed, uncompetitive and non-competitive inhibitors. , 1974, The Biochemical journal.